Shouxiangu(SH:603896) Xin Lang Cai Jing·2025-12-30 03:04Group 1 - The core viewpoint of the news is that Zhejiang Shouxiangu Pharmaceutical Co., Ltd. has shown a stock price increase of 1.24%, reaching 19.56 CNY per share, with a total market capitalization of 3.878 billion CNY [1] - The company specializes in the breeding, cultivation, processing, and sales of precious Chinese medicinal materials, including Ganoderma lucidum and Dendrobium officinale, with its main business revenue composition being 71.92% from Ganoderma spore powder products, 15.57% from Dendrobium products, and 10.88% from other sources [1] Group 2 - Among the top ten circulating shareholders of Shouxiangu, the Rongtong Health Industry Flexible Allocation Mixed A/B fund has increased its holdings by 82,300 shares in the third quarter, now holding 1.2823 million shares, which accounts for 0.65% of the circulating shares [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund has a current scale of 1.816 billion CNY, with a year-to-date return of 9.15% and a one-year return of 4.6% [2] Group 3 - The fund manager of Rongtong Health Industry Flexible Allocation Mixed A/B is Wan Minyuan, who has a total fund asset scale of 5.957 billion CNY, with the best fund return during his tenure being 132.72% and the worst being -25.09% [3]